Better seizure control is possible
You know what it feels like waiting for your next seizure to happen. You deserve more.
Adding Vimpat to your current medications can reduce your partial-onset seizures by 50% or more—something you may have thought was out of reach.
Adding Vimpat to your epilepsy treatment can mean:
- Fewer partial-onset seizures
- Approximately 40% of patients in clinical studies had their partial-onset seizures reduced by half or more
- More seizure-free days
- Better partial-onset seizure control, no matter how many epilepsy medicines you've taken before or are taking now
- Works in even the most difficult-to-treat patients, helping to reduce seizures for those who have not gained seizure control from other medications
- Little effect on weight or memory
- Not having to switch your current medications—simply add on Vimpat
Adding Vimpat can reduce partial-onset seizures by 50% or more
Vimpat has been studied in clinical trials for more than 10 years. When Vimpat was added to or used in combination with every commonly used epilepsy medicine, it was found to improve control of partial-onset seizures in many adults, even those who had tried up to 7 medications. And with Vimpat, better partial-onset seizure control was seen as early as the first week of treatment.
It's important to remember that only your neurologist can decide whether Vimpat is right for you and your treatment plan.
Adding Vimpat can reduce partial-onset seizures by 50% or more*
*Patient may have received more than one anti-epilepsy treatment
Indication
Vimpat® (lacosamide) is a prescription medicine that is used with other medicines to treat partial-onset seizures in people 17 years of age and older with epilepsy.
Important Safety Information
Vimpat is generally well-tolerated, but may not be for everyone. Ask your healthcare provider if Vimpat is right for you.
Warnings and Precautions
Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Do not stop taking Vimpat without first talking to your healthcare provider. Stopping Vimpat suddenly can cause serious problems.
Vimpat may also cause you to feel dizzy, have double vision, feel sleepy, or have problems with coordination and walking. You should not drive, operate machinery or do other dangerous activities until you know how Vimpat affects you.
Vimpat may cause you to have an irregular heartbeat or may cause you to feel faint. Call your healthcare provider if you have a fast, slow, or pounding heartbeat, shortness of breath, feel lightheaded, or if you fainted or feel like you are going to faint.
Vimpat is classified as a federally controlled substance (C-V) due to a low potential for abuse. Keep your Vimpat in a safe place and do not give it to anyone else.
In rare cases, Vimpat may cause a serious allergic reaction that may affect your skin or other parts of your body such as your liver or blood cells. Call your healthcare provider right away if you have a skin rash or hives, fever or swollen glands that do not go away, shortness of breath, swelling of the legs, yellowing of the skin or whites of the eyes, or dark urine.
Vimpat oral solution contains aspartame, a source of phenylalanine.
Common Adverse Reactions
The most common side effects with Vimpat are dizziness, headache, nausea, and double vision. To report Suspected Adverse Reactions, contact UCB, Inc. at 866-822-0068 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see additional patient information in the Patient Medication Guide. This information does not take the place of talking with your healthcare provider about your condition or your treatment.
